Recent PSTX News
- Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema • PR Newswire (US) • 10/24/2024 12:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/22/2024 07:24:01 PM
- Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche • PR Newswire (US) • 10/17/2024 12:00:00 PM
- MaxCyte Appoints Cynthia Collins to its Board of Directors • GlobeNewswire Inc. • 10/15/2024 12:05:00 PM
- Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024 • PR Newswire (US) • 10/03/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 12:00:32 PM
- Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients • PR Newswire (US) • 09/27/2024 08:30:00 PM
- Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma • PR Newswire (US) • 09/16/2024 12:00:00 PM
- Poseida Therapeutics to Present New Clinical Data from Phase 1 Study of Allogeneic CAR-T P-BCMA-ALLO1 in Patients with Relapsed/Refractory Multiple Myeloma at 21st International Myeloma Society Annual Meeting • PR Newswire (US) • 09/05/2024 01:00:00 PM
- Poseida Therapeutics Presents New Case Study Demonstrating Reactivation of CAR-T Therapy with a T-Cell Engager in a Patient with Relapsed Multiple Myeloma • PR Newswire (US) • 09/04/2024 08:05:00 PM
- Poseida Therapeutics to Present at Upcoming Investor Conferences • PR Newswire (US) • 08/29/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2024 04:15:10 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/05/2024 08:33:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 08:10:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:05:24 PM
- Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024 • PR Newswire (US) • 08/05/2024 08:05:00 PM
- Poseida Therapeutics Announces Participation in Stifel's 2024 Virtual Cell Therapy Forum • PR Newswire (US) • 07/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:12:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:10:58 PM
- Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders • PR Newswire (US) • 06/03/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:06:16 PM
- Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/14/2024 08:05:00 PM
- Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting • PR Newswire (US) • 05/09/2024 01:00:00 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM